ID: ALA4285472

Max Phase: Preclinical

Molecular Formula: C35H35N5O7S

Molecular Weight: 669.76

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOc1cc(OC)ccc1C1(N2CCN(c3ccncc3)CC2)C(=O)N(S(=O)(=O)c2ccc(OC)cc2OC)c2ccc(C#N)cc21

Standard InChI:  InChI=1S/C35H35N5O7S/c1-5-47-31-21-26(44-2)7-9-28(31)35(39-18-16-38(17-19-39)25-12-14-37-15-13-25)29-20-24(23-36)6-10-30(29)40(34(35)41)48(42,43)33-11-8-27(45-3)22-32(33)46-4/h6-15,20-22H,5,16-19H2,1-4H3

Standard InChI Key:  JSUNIKSWEDENRJ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 669.76

Molecular Weight (Monoisotopic): 669.2257

AlogP: 4.18

#Rotatable Bonds: 10

Polar Surface Area: 134.53

Molecular Species: BASE

HBA: 11

HBD: 0

#RO5 Violations: 2

HBA (Lipinski): 12

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 8.70

CX LogP: 4.07

CX LogD: 3.23

Aromatic Rings: 4

Heavy Atoms: 48

QED Weighted: 0.24

Np Likeness Score: -0.90

References

1. Geneste H, Bhowmik S, van Gaalen MM, Hornberger W, Hutchins CW, Netz A, Oost T, Unger L..  (2018)  Novel, potent, selective and brain penetrant vasopressin 1b receptor antagonists.,  28  (19): [PMID:30098866] [10.1016/j.bmcl.2018.07.043]

Source

Source(1):

• Scientific Literature